Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

BetterMe Rx vs Boston Medical Group

BetterMe Rx
Graded #235

Lower grade

vs+5
Boston Medical Group
Graded #113

Higher grade

The verdict

Boston Medical Group takes it — 69.9/100 to 64.9/100.

Boston Medical Group grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Established medical group offering a 3-month semaglutide weight loss program.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBoston Medical Group +42
44
86
Dose & formulationBetterMe Rx +23
75
52
Clinical oversightBoston Medical Group +5
84
89
Labs & monitoringBoston Medical Group +1
52
53
FulfillmentBetterMe Rx +23
88
65
Contract termsBoston Medical Group +8
47
55
BetterMe Rx · left barBoston Medical Group · right bar

The numbers

MetricBetterMe RxBoston Medical Group
WeighScore64.9/10069.9/100
GradeCC
Scorecard rank#235#113
Semaglutide$199/mo (promotional rate, compounded)$66/mo (starting dose, compounded)
Tirzepatide$299/mo (promotional rate, compounded)Not disclosed
CoverageAll 50 states7 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
BetterMe Rx

Graded #235 · C

Strengths

  • LegitScript verified
  • All 50 states coverage
  • Six named pharmacy partners with phone numbers — exceptional transparency
  • Both injectable and oral daily tablet formats for sema and tirz
  • Multi-month discounts (3-month and 6-month plans)

Where it loses points

  • No formal corporate entity name or address disclosed
  • Compounded only — no brand-name options
  • Broader platform (HRT, ED, NAD+, Sermorelin, skincare)
  • Headline $199/$299 are limited-time SALE prices; regular prices are $249/$349 per month
Boston Medical Group

Graded #113 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard